Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martijn S Bijker

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Pharmacology & Therapeutics|March 29, 2011
The neuropeptide Y system: pathophysiological and therapeutic implications in obesity and cancerLei Zhang, Martijn S Bijker, Herbert Herzog
Expert Review of Vaccines|August 3, 2007
Design and development of synthetic peptide vaccines: past, present and futureMartijn S Bijker, Cornelis J M Melief, Rienk Offringa, et al.
Advanced Drug Delivery Reviews|September 19, 2006
Improved peptide vaccine strategies, creating synthetic artificial infections to maximize immune efficacySjoerd H van der Burg, Martijn S Bijker, Marij J P Welters, et al.
Nature Immunology|March 18, 2003
Dynamic programming of CD8+ T lymphocyte responsesMarianne J B van Stipdonk, Gijs Hardenberg, Martijn S Bijker, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2007
CD8+ CTL priming by exact peptide epitopes in incomplete Freund's adjuvant induces a vanishing CTL response, whereas long peptides induce sustained CTL reactivityMartijn S Bijker, Susan J F van den Eeden, Kees L Franken, et al.
European Journal of Immunology|March 20, 2008
Superior induction of anti-tumor CTL immunity by extended peptide vaccines involves prolonged, DC-focused antigen presentationMartijn S Bijker, Susan J F van den Eeden, Kees L Franken, et al.
The Journal of Experimental Medicine|April 4, 2007
Spontaneous tumor rejection by cbl-b-deficient CD8+ T cellsStefanie Loeser, Karin Loser, Martijn S Bijker, et al.
Vaccine|November 25, 2006
Multiple CD4 and CD8 T-cell activation parameters predict vaccine efficacy in vivo mediated by individual DC-activating agonistsMarij J P Welters, Martijn S Bijker, Susan J F van den Eeden, et al.
Obesity (Silver Spring, Md.)|May 7, 2011
Peripheral-specific y2 receptor knockdown protects mice from high-fat diet-induced obesityYan-Chuan Shi, Shu Lin, Lesley Castillo, et al.
The Journal of Biological Chemistry|April 28, 2007
Distinct uptake mechanisms but similar intracellular processing of two different toll-like receptor ligand-peptide conjugates in dendritic cellsSelina Khan, Martijn S Bijker, Jimmy J Weterings, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Pharmacology & Therapeutics|March 29, 2011
The neuropeptide Y system: pathophysiological and therapeutic implications in obesity and cancerLei Zhang, Martijn S Bijker, Herbert Herzog
Expert Review of Vaccines|August 3, 2007
Design and development of synthetic peptide vaccines: past, present and futureMartijn S Bijker, Cornelis J M Melief, Rienk Offringa, et al.
Advanced Drug Delivery Reviews|September 19, 2006
Improved peptide vaccine strategies, creating synthetic artificial infections to maximize immune efficacySjoerd H van der Burg, Martijn S Bijker, Marij J P Welters, et al.
Nature Immunology|March 18, 2003
Dynamic programming of CD8+ T lymphocyte responsesMarianne J B van Stipdonk, Gijs Hardenberg, Martijn S Bijker, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2007
CD8+ CTL priming by exact peptide epitopes in incomplete Freund's adjuvant induces a vanishing CTL response, whereas long peptides induce sustained CTL reactivityMartijn S Bijker, Susan J F van den Eeden, Kees L Franken, et al.
European Journal of Immunology|March 20, 2008
Superior induction of anti-tumor CTL immunity by extended peptide vaccines involves prolonged, DC-focused antigen presentationMartijn S Bijker, Susan J F van den Eeden, Kees L Franken, et al.
The Journal of Experimental Medicine|April 4, 2007
Spontaneous tumor rejection by cbl-b-deficient CD8+ T cellsStefanie Loeser, Karin Loser, Martijn S Bijker, et al.
Vaccine|November 25, 2006
Multiple CD4 and CD8 T-cell activation parameters predict vaccine efficacy in vivo mediated by individual DC-activating agonistsMarij J P Welters, Martijn S Bijker, Susan J F van den Eeden, et al.
Obesity (Silver Spring, Md.)|May 7, 2011
Peripheral-specific y2 receptor knockdown protects mice from high-fat diet-induced obesityYan-Chuan Shi, Shu Lin, Lesley Castillo, et al.
The Journal of Biological Chemistry|April 28, 2007
Distinct uptake mechanisms but similar intracellular processing of two different toll-like receptor ligand-peptide conjugates in dendritic cellsSelina Khan, Martijn S Bijker, Jimmy J Weterings, et al.
Pageof 1